Regent Peak Wealth Advisors LLC Eli Lilly & CO Transaction History

Regent Peak Wealth Advisors LLC

$441 Million
Q3 2024

A detailed history of Regent Peak Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Regent Peak Wealth Advisors LLC holds 2,579 shares of LLY stock, worth $1.98 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

2,579

Previous 2,594 0.58%

Holding current value

$1.98 Million

Previous $2.35 Million 2.73%

% of portfolio

0.52%

Previous 0.57%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$772.14 - $960.02 $11,582 - $14,400	-15 Reduced 0.58%	2,579 $2.28 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $39,142 - $49,088	54 Added 2.13%	2,594 $2.35 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $59,220 - $79,228	-100 Reduced 3.79%	2,540 $1.98 Million
Q4 2023 Jan 23, 2024	SELL	$525.19 - $619.13 $16,280 - $19,193	-31 Reduced 1.16%	2,640 $1.54 Million
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $193,006 - $266,089	444 Added 19.94%	2,671 $1.43 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $3,507 - $4,689	-10 Reduced 0.45%	2,227 $1.04 Million
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $13,357 - $15,687	-43 Reduced 1.89%	2,237 $768,000
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $143,732 - $167,477	-447 Reduced 16.39%	2,280 $834,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.71 Million - $1.95 Million	-5,777 Reduced 67.93%	2,727 $881,000
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $202,636 - $237,925	-727 Reduced 7.88%	8,504 $2.76 Million
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $24,642 - $30,624	105 Added 1.15%	9,231 $2.64 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $221,252 - $274,575	-984 Reduced 9.73%	9,126 $2.52 Million
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $26,592 - $32,725	-120 Reduced 1.17%	10,110 $2.34 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $95,330 - $123,309	528 Added 5.44%	10,230 $2.49 Million
Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $71,314 - $92,320	-434 Reduced 4.28%	9,702 $1.81 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $20,351 - $26,930	156 Added 1.56%	10,136 $1.71 Million
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $92,264 - $106,721	631 Added 6.75%	9,980 $1.48 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $5,593 - $6,731	-41 Reduced 0.44%	9,349 $1.54 Million
Q1 2020 Apr 27, 2020	BUY	$119.05 - $147.35 $86,668 - $107,270	728 Added 8.4%	9,390 $1.3 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $926,141 - $1.15 Million	8,662 New	8,662 $1.14 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Peak Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Peak Wealth Advisors LLC with notifications on news.

Account

Regent Peak Wealth Advisors LLC Eli Lilly & CO Transaction History